Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Capital Expenditures (2016 - 2026)

Summit Therapeutics filings provide 13 years of Capital Expenditures readings, the most recent being $746000.0 for Q1 2026.

  • Quarterly Capital Expenditures rose 76.78% to $746000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $981000.0 through Mar 2026, up 76.12% year-over-year, with the annual reading at $657000.0 for FY2025, 372.66% up from the prior year.
  • Capital Expenditures hit $746000.0 in Q1 2026 for Summit Therapeutics, up from $164000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $746000.0 in Q1 2026 and bottomed at -$350000.0 in Q2 2025.
  • Average Capital Expenditures over 5 years is $134941.2, with a median of $53000.0 recorded in 2023.
  • Peak annual rise in Capital Expenditures hit 10450.0% in 2025, while the deepest fall reached 655.56% in 2025.
  • Summit Therapeutics' Capital Expenditures stood at -$10000.0 in 2022, then surged by 120.0% to $2000.0 in 2023, then skyrocketed by 6850.0% to $139000.0 in 2024, then rose by 17.99% to $164000.0 in 2025, then surged by 354.88% to $746000.0 in 2026.
  • Per Business Quant, the three most recent readings for SMMT's Capital Expenditures are $746000.0 (Q1 2026), $164000.0 (Q4 2025), and $421000.0 (Q3 2025).